A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade

Immune checkpoint blockade (ICB) is efficacious in many diverse cancer types, but not all patients respond. It is important to understand the mechanisms driving resistance to these treatments and to identify predictive biomarkers of response to provide best treatment options for all patients. Here w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ivy X., Newcomer, Kathleen, Pauken, Kristen E., Juneja, Vikram R., Naxerova, Kamila, Wu, Michelle W., Pinter, Matthias, Sen, Debattama R., Singer, Meromit, Sharpe, Arlene H., Jain, Rakesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2020
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519254/
https://www.ncbi.nlm.nih.gov/pubmed/32907939
http://dx.doi.org/10.1073/pnas.2002806117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519254/
https://www.ncbi.nlm.nih.gov/pubmed/32907939
http://dx.doi.org/10.1073/pnas.2002806117

Ejemplares similares